Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Effect of an Asthma Guideline in 2 Pediatric Emergency Departments and an Urgent Care Center.

Dilts JJ, Humiston SG, Lee BR, Allen NH, Michael JG.

Pediatr Emerg Care. 2018 Oct;34(10):729-735. doi: 10.1097/PEC.0000000000001058.

PMID:
28169982
2.

Interexaminer agreement in physical examination for children with suspected soft tissue abscesses.

Giovanni JE, Dowd MD, Kennedy C, Michael JG.

Pediatr Emerg Care. 2011 Jun;27(6):475-8. doi: 10.1097/PEC.0b013e31821d8545.

PMID:
21629150
3.

Microencapsulation: the future of oral immunotherapy?

Litwin A, Flanagan M, Michael JG.

BioDrugs. 1998 Apr;9(4):261-70.

PMID:
18020564
4.
5.

Management of corneal abrasion in children: a randomized clinical trial.

Michael JG, Hug D, Dowd MD.

Ann Emerg Med. 2002 Jul;40(1):67-72.

PMID:
12085075
7.

Abrogation of oral tolerance by feeding encapsulated antigen.

Barone KS, Reilly MR, Flanagan MP, Michael JG.

Cell Immunol. 2000 Feb 1;199(2):65-72.

PMID:
10698615
8.

Case records of the Children's Mercy Hospital, Case 02-1999: a 1-month-old infant with respiratory distress and shock.

Knapp JF, Michael JG, Hegenbarth MA, Jones PE, Black PG.

Pediatr Emerg Care. 1999 Aug;15(4):288-93. No abstract available.

PMID:
10460091
9.

Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes.

Hong SJ, Michael JG, Fehringer A, Leung DY.

J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):473-8.

PMID:
10452774
11.

Induction of oral tolerance in TGF-beta 1 null mice.

Barone KS, Tolarova DD, Ormsby I, Doetschman T, Michael JG.

J Immunol. 1998 Jul 1;161(1):154-60.

12.

Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: a double-blind study.

Litwin A, Flanagan M, Entis G, Gottschlich G, Esch R, Gartside P, Michael JG.

J Allergy Clin Immunol. 1997 Jul;100(1):30-8.

PMID:
9257784
13.

Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen.

Jain SL, Barone KS, Flanagan MP, Michael JG.

Vaccine. 1996 Sep;14(13):1291-7.

PMID:
8961521
14.

Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.

Litwin A, Flanagan M, Entis G, Gottschlich G, Esch R, Gartside P, Michael JG.

Ann Allergy Asthma Immunol. 1996 Aug;77(2):132-8.

PMID:
8760779
15.

Breaking of oral tolerance by an encapsulated antigen.

Flanagan M, Jain S, Michael JG.

Ann N Y Acad Sci. 1996 Feb 13;778:373-5. No abstract available.

PMID:
8610994
16.

Activation patterns of murine T cells after oral administration of an enterocoated soluble antigen.

Jain SL, Barone KS, Michael JG.

Cell Immunol. 1996 Feb 1;167(2):170-5.

PMID:
8603425
17.

Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen.

Jain SL, Barone KS, Flanagan MP, Michael JG.

Vaccine. 1996 Jan;14(1):42-8. Corrected and republished in: Vaccine. 1996 Sep;14(13):1291-7.

PMID:
8821648
18.

Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance.

Barone KS, Jain SL, Michael JG.

Cell Immunol. 1995 Jun;163(1):19-29.

PMID:
7758127
19.

The influence of antigen digestion on orally induced immunity and tolerance.

Jain SL, Michael JG.

Adv Exp Med Biol. 1995;371B:1245-50.

PMID:
7502793
20.
21.
22.

Artifacts and limitations of enzyme immunoassay.

Pesce AJ, Michael JG.

J Immunol Methods. 1992 Jun 24;150(1-2):111-9. Review. No abstract available.

PMID:
1613248
25.

Modulation of the immune response to ragweed allergens by peptic fragments.

Michael JG, Litwin A, Hassert V, Pesce A.

Clin Exp Allergy. 1990 Nov;20(6):669-74.

PMID:
2083407
26.

Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment.

Zhang ZY, Michael JG.

J Immunol. 1990 Jun 1;144(11):4163-5.

PMID:
2140388
27.

Cationization of protein antigens. V. Effect of the degree of cationization on patterns of immune responsiveness.

Muckerheide A, Pesce AJ, Michael JG.

Cell Immunol. 1990 Apr 15;127(1):67-77.

PMID:
1690611
28.

Modulation of the immune response to allergens: phospholipase A degradation products suppress IgG and IgE response in mice.

Pesce AJ, Freisheim JM, Litwin A, Michael JG.

Int Arch Allergy Appl Immunol. 1990;92(1):88-93.

PMID:
2246080
29.

The role of digestive enzymes in orally induced immune tolerance.

Michael JG.

Immunol Invest. 1989 Nov-Dec;18(9-10):1049-54.

PMID:
2515155
30.

Cationization of protein antigens. IV. Increased antigen uptake by antigen-presenting cells.

Apple RJ, Domen PL, Muckerheide A, Michael JG.

J Immunol. 1988 May 15;140(10):3290-5.

PMID:
3258879
31.

C3 dependent, C5 independent immune complex glomerulopathy in the mouse.

Sawtell NM, Hartman AL, Weiss MA, Pesce AJ, Michael JG.

Lab Invest. 1988 Mar;58(3):287-93.

PMID:
2964544
32.
33.

Cationization of protein antigens. III. Abrogation of oral tolerance.

Domen PL, Muckerheide A, Michael JG.

J Immunol. 1987 Nov 15;139(10):3195-8.

PMID:
3680943
34.

Cationization of protein antigens. II. Alteration of regulatory properties.

Muckerheide A, Domen PL, Michael JG.

J Immunol. 1987 May 1;138(9):2800-4.

PMID:
3494770
35.
37.

Peptic fragments of bovine serum albumin bind antigen-specific T suppressor cells from orally tolerized mice.

Zhang Z, Apple RJ, Pesce A, Michael JG.

Cell Immunol. 1987 Feb;104(2):426-33.

PMID:
2949858
38.

Cationization of protein antigens. I. Alteration of immunogenic properties.

Muckerheide A, Apple RJ, Pesce AJ, Michael JG.

J Immunol. 1987 Feb 1;138(3):833-7.

PMID:
2433331
39.

Cationic antigens. Problems associated with measurement by ELISA.

Pesce AJ, Apple R, Sawtell N, Michael JG.

J Immunol Methods. 1986 Feb 27;87(1):21-7.

PMID:
2419448
40.

Expression of normal and tumor-associated antigens in human breast carcinoma.

Sawtell NM, DiPersio L, Michael JG, Pesce AJ, Weiss MA.

Lab Invest. 1984 Aug;51(2):225-32.

PMID:
6087025
41.

Kinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigen.

Saklayen MG, Pesce AJ, Pollak VE, Michael JG.

Int Arch Allergy Appl Immunol. 1984;73(1):5-9.

PMID:
6693181
42.
43.

The antigenic structure of proteins: a reappraisal.

Benjamin DC, Berzofsky JA, East IJ, Gurd FR, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, et al.

Annu Rev Immunol. 1984;2:67-101. Review. No abstract available.

PMID:
6085753
44.

Induction of oral tolerance in mice unresponsive to bacterial lipopolysaccharide.

Saklayen MG, Pesce AJ, Pollak VE, Michael JG.

Infect Immun. 1983 Sep;41(3):1383-5.

45.

Immunoregulation of the anti-bovine serum albumin response by polyclonal and monoclonal antibodies.

Krieger NJ, Pesce A, Michael JG.

Cell Immunol. 1983 Sep;80(2):279-87.

PMID:
6192937
46.

Immunoregulatory properties of antigenic fragments from bovine serum albumin.

Ferguson TA, Peters T Jr, Reed R, Pesce AJ, Michael JG.

Cell Immunol. 1983 May;78(1):1-12.

PMID:
6601999
47.

Enhancement of antigen-specific suppression by muramyl dipeptide.

Ferguson TA, Krieger NJ, Pesce A, Michael JG.

Infect Immun. 1983 Feb;39(2):800-6.

48.
49.

Molecular and cellular events in normal and abnormal immune responsiveness.

Michael JG, Krieger NJ.

Clin Physiol Biochem. 1983;1(2-5):179-93. Review. No abstract available.

PMID:
6084575
50.

Concomitant enhancement of B-cell mitogenesis and inhibition of antibody synthesis by a phorbol ester.

Ferguson TA, Fish LA, Baxter CS, Michael JG.

Proc Soc Exp Biol Med. 1982 Oct;171(1):83-7. No abstract available.

PMID:
6983078

Supplemental Content

Loading ...
Support Center